SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-017978
Filing Date
2021-07-28
Accepted
2021-07-28 16:01:56
Documents
53
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 742390
2 ex31-1.htm EX-31.1 19544
3 ex31-2.htm EX-31.2 19838
4 ex32.htm EX-32 13730
5 form10-q_001.jpg GRAPHIC 25344
  Complete submission text file 0001493152-21-017978.txt   3773472

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abeo-20210630.xsd EX-101.SCH 25146
7 XBRL CALCULATION FILE abeo-20210630_cal.xml EX-101.CAL 51453
8 XBRL DEFINITION FILE abeo-20210630_def.xml EX-101.DEF 95461
9 XBRL LABEL FILE abeo-20210630_lab.xml EX-101.LAB 238150
10 XBRL PRESENTATION FILE abeo-20210630_pre.xml EX-101.PRE 192232
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 564480
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 211122518
SIC: 2834 Pharmaceutical Preparations